Molecular Profiling Guides Adjuvant Endometrial Cancer Treatment with Reduced Early Toxicity
Results from the phase 3 PORTEC-4a trial show that tailoring adjuvant therapy by molecular risk profile significantly curtails early toxicities ...
Results from the phase 3 PORTEC-4a trial show that tailoring adjuvant therapy by molecular risk profile significantly curtails early toxicities ...
A case report documents the co-occurrence of ovarian serous cystadenoma, mature cystic teratoma, and a polycystic ovary syndrome-like phenotype in ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.